Choledochoscopy Multicenter Registry

Status unconfirmed

Conditions studied: Pancreatico-biliary Disorder

In brief

The purpose of this registry is to record information and evaluate the impact of SpyGlassTM Direct Visualization System for choledochoscopy on the management of pancreatico-biliary disorders. The registry will evaluate diagnostic performance and overall clinical management impacted by SpyGlass. This multi-center registry has been initiated: * To document the impact of SpyGlass Choledochoscopy in pancreatico-biliary disorders on the clinical management of pancreatico-biliary disorders including malignancies. * To assess the sensitivity, specificity, accuracy, technical feasibility, safety and cost effectiveness of SpyGlass and compare it to other diagnostic modalities.

Key facts

Study ID

NCT02166099

Run by

Weill Medical College of Cornell University

People needed

250

Starts

2012-10-01

Expected to finish

2018-12-30

Last updated by the study team

2017-02-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any patient who has undergone SpyGlass Choledochoscopy procedures for diagnosis and/or treatment of a pancreatico-biliary disorder
• Above 18 years of age

You may not qualify if…

• Any patient who has not undergone choledochoscopy for pancreatico-biliary disorders
• Below 18 years of age

Where it is running

• Weill Cornell Medical College — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.